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In the title compound, C 15 H 8 Cl 2 F 2 O, the C C double bond is in the E configuration. In the cyrstal, C-HÁ Á ÁO hydrogen bonds connect the molecules into chains along the c axis. Ainteraction of 3.628 (1) Å is also observed between two polyhalogenated benzene rings. The dichlorosubstituted ring exhibits partial disorder over two sets of sites, with siteoccupancy factors of 0.573 (3) and 0.427 (3).
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Experimental
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: WN2465). Chalcones constitute an important group of natural products and some of them possess a wide range of biological activities, such as antibacterial (Nielsen et al., 2004) and anticancer (Modzelewska et al., 2006) . A review of anti-infective and antiinflammatory chalcones (Nowakowska, 2007) and recent advances in therapeutic chalcones have been reported (Ni et al., 2004) . Related crystal structures of some chalcones, e.g. 1-(2,4-dichloro-5-fluorophenyl)-3-(3,4-dimethoxyphenyl)prop-2en-1-one (Yathirajan et al., 2006) and (2E)-1-(2,4-dichlorophenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one (Yathirajan et al., 2007) have been reported. As part of our ongoing studies on chalcones (Betz et al., 2011) , the title compound was synthesized and its crystal structure is reported here.
Structure Reports Online
The C═C double bond of the Michael system is in the E configuration. The fluorine atom on the polyhalogenated phenyl ring, together with its attached carbon atom is disordered over two sites, as are the ring CH meta to it. The site occupancy factors refined to 0.573 (3) and 0.427 (3). The least-squares planes defined by the carbon atoms of the two rings make a dihedral angle of 82.37 (8)° (Fig. 1 ).
In the crystal structure, intermolecular C-H···O hydrogen bonds are observed (Table 1 and Fig. 2) , forming a 6membered chelate ring. In terms of graph-set analysis (Etter et al., 1990; Bernstein et al., 1995) , the descriptor for this pattern is C 1 1 (5)C 1 1 (7) on the unitary level. Molecules are connected into chains along the crystallographic c axis. A π-π interaction of 3.628 (1) Å is also observed between two polyhalogenated phenyl rings. The packing of the title compound in the crystal structure is shown in Fig. 3 .
Experimental
To a stirred solution of 1-(2,6-dichloro-3-fluorophenyl)ethanone (1 g, 4.8 mmol) and 4-fluorobenzaldehyde (0.59 g, 4.8 mmol) in ethanol (10 ml), powdered KOH (0.4 g 7.2 mmol) was added at 273 K. The reaction mixture was stirred at room temperature for 1 h. After completion of the reaction, the reaction mixture was poured into ice cold water and acidified with 1.5 N HCl (pH ~3). The resulting precipitate was filtered and dried to afford 1.3 g of the title compound as a pale yellow solid in 86% yield. Single crystals suitable for the diffraction study were grown from a mixture of toluene:acetone (v:v = 1:1) by slow evaporation at room temperature (m.p.: 421-424 K).
Refinement
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